Carbamic acid |
| Catalog No.GC31273 |
카르밤산은 도파민성 시스템이 파괴된 하나 이상의 장애 또는 상태, 예를 들어 정신분열증 및 기타 정신병 상태로 이루어진 군으로부터 독립적으로 선택된 하나 이상의 장애 또는 상태; 기분 장애 ADHD; 침략; 운동 장애.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 908608-06-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Carbamic acid, N-[2,4-dimethyl-6-(4-morpholinyl)-3-pyridinyl]-, phenylmethyl ester is a new invention for treating, one or more disorders or conditions wherein the dopaminergic system is disrupted, such as one or more disorders or conditions independently selected from the group consisting of: schizophrenia and other psychotic states; mood disorders ADHD; aggression; movement disorders.
[1]. Henriette Husum Bak-Jensen, et al. Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted. WO 2009015667 A1
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *